GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Change In Receivables

Asymchem Laboratories Tianjin Co (SZSE:002821) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Change In Receivables?

Asymchem Laboratories Tianjin Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Asymchem Laboratories Tianjin Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥501 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Receivable declined by ¥501 Mil from Dec. 2022 to Dec. 2023 .

Asymchem Laboratories Tianjin Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,713 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Asymchem Laboratories Tianjin Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 111.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Asymchem Laboratories Tianjin Co's liquidation value for the three months ended in Mar. 2024 was ¥8,529 Mil.


Asymchem Laboratories Tianjin Co Change In Receivables Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Change In Receivables Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -161.89 -421.83 -1,062.12 -586.12 500.83

Asymchem Laboratories Tianjin Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Asymchem Laboratories Tianjin Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co  (SZSE:002821) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Asymchem Laboratories Tianjin Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1712.927/1399.808*91
=111.66

2. In Ben Graham's calculation of liquidation value, Asymchem Laboratories Tianjin Co's accounts receivable are only considered to be worth 75% of book value:

Asymchem Laboratories Tianjin Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=8982.65-2234.465+0.75 * 1712.927+0.5 * 992.331
=8,529

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.
Executives
Xiao Yi Executives
Xu Xiang Ke Directors, executives
Zhou Yan Executives
Chen Chao Yong Executives
Huang Xiao Lian Executives
Yang Jing Director
Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines